Clinical Trials Directory

Trials / Completed

CompletedNCT01384864

Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Anandasabapathy, Sharmila, M.D. · Individual
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The overall objective of this pilot study is to determine whether multispectral imaging increases the diagnostic accuracy of the current standard of high-definition white-light endoscopy for the detection of Barrett's-associated neoplasia (high grade dysplasia or cancer). The investigators goal is to develop a multispectral endoscopic platform that can be used to survey a large surface area and, potentially, serve as a 'red flag' for microendoscopic imaging of small areas. The goal of this pilot study is to preliminarily determine the accuracy of these modalities during the endoscopic surveillance of Barrett's esophagus.

Conditions

Interventions

TypeNameDescription
DRUGproflavine2-6 ml of 0.01% proflavine

Timeline

Start date
2011-08-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2011-06-29
Last updated
2016-01-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01384864. Inclusion in this directory is not an endorsement.

Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia (NCT01384864) · Clinical Trials Directory